Sander I. van Leuven
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 4
- Rheumatology top 2%
- Systemic Lupus Erythematosus Research 10
- Immunology top 5%
- Atherosclerosis and Cardiovascular Diseases 21
- Surgery top 5%
- Lipoproteins and Cardiovascular Health 10
-
- Systemic Sclerosis and Related Diseases 8
-
- Adipokines, Inflammation, and Metabolic Diseases 6
-
- Cancer, Lipids, and Metabolism 5
-
- Pulmonary Hypertension Research and Treatments 5
- Co-authors
- John J.P. KasteleinErik S.G. StroesMichiel L. BotsJan Albert KuivenhovenPaul P. TakWard A. RileyCharles L. ShearJames H. Revkin
- Journals
- Lara D. Veeken (6 papers)Annals of the Rheumatic Diseases (3 papers)Atherosclerosis (3 papers)
- Partner nations
- NetherlandsUnited StatesUnited Kingdom
In The Last Decade
Sander I. van Leuven
45 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 111
- Endocrinology, Diabetes and Metabolism 448
- Rheumatology 394
- Immunology 458
- Cardiology and Cardiovascular Medicine 449
- Surgery 683
Countries citing papers authored by Sander I. van Leuven
This map shows the geographic impact of Sander I. van Leuven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sander I. van Leuven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sander I. van Leuven more than expected).
Fields of papers citing papers by Sander I. van Leuven
This network shows the impact of papers produced by Sander I. van Leuven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sander I. van Leuven. The network helps show where Sander I. van Leuven may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sander I. van Leuven, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 4 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 1 | |
| 6 | 2022 | 11 | |
| 7 | 2017 | 25 | |
| 8 | 2016 | 10 | |
| 9 | 2010 | 46 | |
| 10 | 2010 | 26 | |
| 11 | 2008 | 15 | |
| 12 | 2008 | 8 | |
| 13 | 2008 | 58 | |
| 14 | 2008 | 203 | |
| 15 | 2007 | 1 | |
| 16 | 2007 | 135 | |
| 17 | 2007 | 475 | |
| 18 | 2007 | 80 | |
| 19 | Abstract 1497: Enhanced atherogenesis and altered High Density Lipoprotein in patients with Crohn's Disease | 2006 | 1 |
| 20 | 2005 | 7 |
About Sander I. van Leuven
Sander I. van Leuven is a scholar working on Immunology, Rheumatology and Immunology and Allergy, having authored 45 papers that have together received 1.8k indexed citations. Recurring topics across this work include Atherosclerosis and Cardiovascular Diseases (21 papers), Lipoproteins and Cardiovascular Health (10 papers), Systemic Lupus Erythematosus Research (10 papers), Systemic Sclerosis and Related Diseases (8 papers), Adipokines, Inflammation, and Metabolic Diseases (6 papers), Cancer, Lipids, and Metabolism (5 papers), Pulmonary Hypertension Research and Treatments (5 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (448 citations), Rheumatology (394 citations) and Immunology (458 citations). Sander I. van Leuven has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include John J.P. Kastelein, Erik S.G. Stroes, Michiel L. Bots, Jan Albert Kuivenhoven, Paul P. Tak, Ward A. Riley, Charles L. Shear, James H. Revkin, Greg Evans and Diederick E. Grobbee. Their work appears in journals such as Lara D. Veeken, Annals of the Rheumatic Diseases, Atherosclerosis, Arteriosclerosis Thrombosis and Vascular Biology and Current Opinion in Lipidology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.